Cargando…

Transient Pulmonary Interstitial Lesions in Aquaporin-4-positive Neuromyelitis Optica Spectrum Disorder

We herein report the case of a 76-year old man with aquaporin-4-Immunoglobulin-G(AQP4-IgG)-positive neuromyelitis optica spectrum disorder (NMOSD), in whom transient interstitial pulmonary lesions developed at the early stage of the disease. Chest X-ray showed multiple infiltrative shadows in both u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asato, Yuko, Kamitani, Toshiaki, Ootsuka, Kuniyuki, Kuramochi, Mizuki, Nakanishi, Kozo, Shimada, Tetsuya, Takahashi, Toshiyuki, Misu, Tatsuro, Aoki, Masashi, Fujihara, Kazuo, Kawabata, Yoshinori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232019/ https://www.ncbi.nlm.nih.gov/pubmed/29780127 http://dx.doi.org/10.2169/internalmedicine.0580-17

Ejemplares similares

Cerebrospinal Fluid Aquaporin-4 Antibody Levels in Neuromyelitis Optica Attacks
por: Sato, Douglas Kazutoshi, et al.
Publicado: (2014)

Pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders
por: Takai, Yoshiki, et al.
Publicado: (2023)

Optic neuritis after ocular trauma in anti‐aquaporin‐4 antibody‐positive neuromyelitis optica spectrum disorder
por: Akaishi, Tetsuya, et al.
Publicado: (2021)

Early Treatment Initiation With Oral Prednisolone for Relapse Prevention Alleviates Depression and Fatigue in Aquaporin-4–Positive Neuromyelitis optica Spectrum Disorder
por: Akaishi, Tetsuya, et al.
Publicado: (2021)

Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody
por: Kurosawa, Kazuhiro, et al.
Publicado: (2015)

Progressive patterns of neurological disability in multiple sclerosis and neuromyelitis optica spectrum disorders
por: Akaishi, Tetsuya, et al.
Publicado: (2020)

CH50 as a putative biomarker of eculizumab treatment in neuromyelitis optica spectrum disorder
por: Namatame, Chihiro, et al.
Publicado: (2021)

Complement-dependent and -independent aquaporin 4-antibody-mediated cytotoxicity in human astrocytes: Pathogenetic implications in neuromyelitis optica
por: Nishiyama, S., et al.
Publicado: (2016)

Neuromyelitis optica pathogenesis and aquaporin 4
por: Graber, David J, et al.
Publicado: (2008)

Antibody to Aquaporin 4 in the Diagnosis of Neuromyelitis Optica
por: Paul, Friedemann, et al.
Publicado: (2007)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
por: Schanda, Kathrin, et al.
Publicado: (2015)

White blood cell count profiles in anti-aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder and anti-myelin oligodendrocyte glycoprotein antibody-associated disease
por: Akaishi, Tetsuya, et al.
Publicado: (2023)

Neuromyelitis optica spectrum disorders: still evolving and broadening
por: Fujihara, Kazuo
Publicado: (2019)

T cell-activation in neuromyelitis optica lesions plays a role in their formation
por: Pohl, Maria, et al.
Publicado: (2013)

Severe aquaporin 4-IgG-positive neuromyelitis optica with disseminated herpes zoster in a pregnant woman successfully treated with intravenous immunoglobulin
por: Matsumoto, Yuki, et al.
Publicado: (2018)

Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica
por: Misu, Tatsuro, et al.
Publicado: (2013)

Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder
por: Akaishi, Tetsuya, et al.
Publicado: (2021)

Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats
por: Kitic, Maja, et al.
Publicado: (2013)

Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat
por: Hillebrand, Sophie, et al.
Publicado: (2018)

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
por: Jarius, S., et al.
Publicado: (2008)

Patterns of Antibody Binding to Aquaporin-4 Isoforms in Neuromyelitis Optica
por: Mader, Simone, et al.
Publicado: (2010)

Differential diagnosis of neuromyelitis optica spectrum disorders
por: Kim, Sung-Min, et al.
Publicado: (2017)

Serological markers associated with neuromyelitis optica spectrum disorders in South India
por: Pandit, Lekha, et al.
Publicado: (2016)

Immunodominant T Cell Determinants of Aquaporin-4, the Autoantigen Associated with Neuromyelitis Optica
por: Nelson, Patricia A., et al.
Publicado: (2010)

Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders
por: Tzartos, John S., et al.
Publicado: (2013)

Convergence spasm due to aquaporin-positive neuromyelitis optica spectrum disorder
por: Özçelik, Pınar, et al.
Publicado: (2017)

Radiologically isolated aquaporin-4 antibody neuromyelitis optica spectrum disorder
por: Abdel-Mannan, Omar, et al.
Publicado: (2022)

Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders
por: Palace, Jacqueline, et al.
Publicado: (2019)

Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology
por: Fujihara, Kazuo, et al.
Publicado: (2020)

Detection of anti-aquaporin-4 autoantibodies in the sera of Chinese neuromyelitis optica patients★
por: Li, Miao, et al.
Publicado: (2013)

Fatal anti-aquaporin-4 seropositive neuromyelitis optica spectrum disorder in tuberculosis
por: Sridhar, Siddharth, et al.
Publicado: (2014)

Evaluation of Clinical Interest of Anti-Aquaporin-4 Autoantibody Followup in Neuromyelitis Optica
por: Chanson, Jean-Baptiste, et al.
Publicado: (2013)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
por: Waters, Patrick, et al.
Publicado: (2016)

The single nucleotide polymorphism site of aquaporin-4 gene in patients with neuromyelitis optica
por: Wang, Qing-Song, et al.
Publicado: (2017)

Are aquaporin antibody titers useful outcome measures for neuromyelitis optica spectrum disorders?
por: Reindl, Markus
Publicado: (2020)

COVID-19 in a patient treated with eculizumab for aquaporin-4 neuromyelitis optica
por: Cabal-Herrera, Ana Maria, et al.
Publicado: (2021)

Neuromyelitis Optica
por: Misra, M. C., et al.
Publicado: (1953)

Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder
por: Wingerchuk, Dean M., et al.
Publicado: (2021)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)

Three cases of neuromyelitis optica spectrum disorder
por: Matsusue, Eiji, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_crcjm9gfhidsep3asaef61j479